Join us for AAPS 2023
Quotient Sciences drug development experts will be back for another great year at AAPS PharmSci 360 in Orlando, FL in October. Join us at booth #2509 to discuss your drug development needs and be sure to join us for our seminar, partner presentation, and poster sessions that are also happening during the event. Get details on everything happening at the event below.
"A Formulator’s Guide to Crossing the Valley of Death": Co-presented with Quotient Sciences & Charles River
Tuesday, October 24 | 3:30 – 4:30 PM
The translation from early discovery to the clinic has been termed the ‘Valley of Death’ as approximately 95% of compounds fail to make it to later clinical stages. It is estimated that the majority of failures in Phase 2 are due to poor efficacy due to poor exposure. Controlling drug properties and early consideration of appropriate formulation strategies during development can reduce risks down the road, minimizing challenges for the formulation scientist. Join our discussion co-presented with Charles River, featuring Dr. Dolly Jacob, Director Integrated Development Services at Quotient Sciences, and Dr. Darren Matthews, Associate Science Director at Charles River.
Registration is not required. This presentation is open for any to attend and takes place on Stage 2.
"How to Accelerate Drug Product Optimization Using Translational Pharmaceutics®"
Tuesday, October 24
Breakfast & registration beginning at 7:15 AM
Join us during AAPS for our breakfast seminar at the Hyatt on October 24. Dr. Aruna Railkar, Senior Drug Development Consultant critically evaluates the existing reformulation paradigm, describes our Translational Pharmaceutics approach, and shares insights gained from 15 years of experience in accelerating the drug product optimization process using real-world case studies to get new medicines to patients in need faster.
Advanced registration is required and spaces are limited!
Monday, October 23 | 9:30–10:30 AM
Formulation Optimization of EVX-101, a Novel Gastro-Retentive Prolonged-Release 5-HTP/Low-Dose Carbidopa Tablet
Presenting Author: Dr. Aruna Railkar
Tuesday, October 24 | 2:30–3:30 PM
Development of Hydrogel Polymer-Based Bilayer Gastro-Retentive Modified-Release Tablets
Presenting Author: Ching Sieu Tay, MS
Presentation times to be announced
A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food Effect in Healthy Volunteers
Development of an Extended Release Nafamostat Formulation for Prescription Drug Overdose Protection
Presenting Author: Dr. Dolly Jacob
Use of Resonant Acoustic Technology for Ultra-Low Dose Blending in a Single-Step Mixing Process
Presenting Author: Kyle Frey
Get your drug development questions answered by our experts and network with our extended team. Schedule a 1:1 meeting with anyone from our team at the event by filling out the form below.
- Eleanor Row - Executive Director and Candidate Development Leader
- Dolly Jacob - Director, Integrated Development Services,
- Brad Rowe - Senior Director, Integrated Development Services
- Aruna Railkar - Senior Drug Development Consultant
- Katie Stuart - Senior Director, Business Development
- Connie Scott - Senior Director, Business Development
- Jennifer Lattimer - Director of Business Development
- Kyle Corcoran - Director of Business Development
- Dan Dennehy - Director Of Business Development